AVE 20.0% 0.2¢ avecho biotechnology limited

pre announce, page-32

  1. 5,270 Posts.
    lightbulb Created with Sketch. 244

    Like Karicoum, I'd be very interested in your evaluation of the trial data at the link.

    http://www.mastitis-management-australia.com/2652.html

    BTW, I believe that the the use of the term non-therapeutic intends to convey that the product is intended to be used as an "over the counter" product without necessarily involving a vet. It's pretty clear though that the product is intended to "treat" mastitis as an alternative to antibiotics.

    As I said, I'd be very interested in your take on this after having a look at the linked data.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.